Myriad Genetics Enters Oversold Territory - Tale of the Tape

By
A A A

Myriad Genetics, Inc. 's ( MYGN ) share price has entered into oversold territory with a stochastic value of 17.588. The Zacks Consensus Estimate on the company's earnings for June 2012 increased by 2 cents over the past month to $1.26 per share. Myriad Genetics is a Zacks #2 Rank ("Buy") company.


 
MYRIAD GENETICS ( MYGN ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: MYGN

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Spot the Dropout RRC
Spot the Dropout RRC                
Spot the Dropout MG
Spot the Dropout MG                 
Spot the Dropout IPC
Spot the Dropout IPC                

Stocks

Referenced

Most Active by Volume

82,115,651
  • $95.21 ▼ 1.84%
63,856,529
  • $18.13 ▼ 0.17%
41,286,059
  • $5.19 ▼ 6.49%
39,091,664
  • $46.88 ▲ 1.27%
37,020,854
  • $3.97 ▲ 0.51%
34,682,490
  • $15.10 ▼ 0.72%
33,806,837
  • $36.08 ▼ 11.61%
31,373,599
  • $122.37 ▼ 0.50%
As of 7/30/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com